Trials / Completed
CompletedNCT00467428
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder. A Randomised, Double-Blind, Placebo-Controlled Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- NeuroSearch A/S · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate if NS2359 is effective in the treatment of ADHD in adult patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NS2359 | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-08-01
- Completion
- 2004-09-01
- First posted
- 2007-04-30
- Last updated
- 2007-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00467428. Inclusion in this directory is not an endorsement.